BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corsetti M, Pannemans J, Whorwell P. Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders? F1000Res 2019;8:F1000 Faculty Rev-257. [PMID: 30863534 DOI: 10.12688/f1000research.15974.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Coluzzi F, Scerpa MS, Pergolizzi J. Naldemedine: A New Option for OIBD. J Pain Res 2020;13:1209-22. [PMID: 32547183 DOI: 10.2147/JPR.S243435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
2 Melchior C, Desprez C, Wuestenberghs F, Leroi AM, Lemaire A, Goucerol G. Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders. Front Pharmacol 2020;11:596467. [PMID: 33414719 DOI: 10.3389/fphar.2020.596467] [Reference Citation Analysis]
3 Malinky CA, Lindsley CW, Han C. DARK Classics in Chemical Neuroscience: Loperamide. ACS Chem Neurosci 2021;12:2964-73. [PMID: 34346690 DOI: 10.1021/acschemneuro.1c00382] [Reference Citation Analysis]